|10-16-2018 04:37 PM CET - Health & Medicine||
Prostate Cancer Therapeutics Market Competitive Landscape 2018-2025: Sanofi, Ferring Pharmaceuticals, Takeda Pharmaceutical Company Ltd, Teva Pharmaceuticals, AstraZeneca, Astellas Pharma, Bristol-Myers Squibb, Active Biotech AB, Ipsen, Sanpower Group
Press release from: Data Bridge Market Research
Prostate cancer therapeutics market is going to have a rocket boom for their sales, import, export and revenue in the forecast period of 2018-2025.
The report is generated based on the market type, size of the organization, availability on-premises and the end-users’ organization type, and the availability in areas such as North America, South America, Europe, Asia-Pacific and Middle East & Africa.
The base year for calculation in the report is taken as 2017 the historic year is 2016 which will tell you how the prostate cancer therapeutics market is going to perform in the forecast years by informing you what the market definition, classifications, applications, and engagements are, and how the top players are performing in when it comes to their recent product launches, their researches, their joint ventures, merges, and accusations.
To request a sample copy or view summary of this report, click the link below: databridgemarketresearch.com/request-a-sample/?dbmr=globa...
Key Players Covered in this Report:
• Tolmar INC,
• Ferring Pharmaceuticals,
• Takeda pharmaceutical co. Ltd.,
• Teva Pharmaceutical Industries LTD,
• Sanofi-Aventis, Pfizer Inc,
• Johnson & Johnson,
• Endo Pharmaceuticals Inc (Indevus Pharmaceuticals Inc) ,
• Dendreon Corporation,
• Abbott Laboratories,
• Bayer AG,
• Dendreon Corporation (Sanpower Group Co. Ltd.),
• AbbVie, Inc. among others.
The global prostate cancer therapeutics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of prostate cancer therapeutics market for global, Europe, North America, Asia Pacific and South America.
Major Topics Covered:
2. Market Segmentation
3. Executive Summary
4. Market Overview
5. Premium Insights
6. Global Prostate Cancer Therapeutics Market: Regulatory Scenario
7. Global Prostate Cancer Therapeutics Market, By Drug Type
8. Global Prostate Cancer Therapeutics Market, By Distribution Channel
9. Global Prostate Cancer Therapeutics Market, By End User
10. Global Prostate Cancer Therapeutics, By Geography
11. Global Prostate Cancer Therapeutics, Company Landscape
12. Company Profiles
13. Related Reports
Any Questions? Inquiry before Buying Visit @ databridgemarketresearch.com/inquire-before-buying/?dbmr=...
Key Developments in the Market:
In May 2018, Ferring Pharmaceuticals has done an agreement giving the company the option to secure global commercialisation rights to nadofaragene firadenovec/Syn3 (rAd-IFN/Syn3), a novel gene therapy that is being developed by FKD Therapies Oy (FKD) as a treatment for patients with high-grade non-muscle invasive bladder cancer (NMIBC), who are unresponsive to Bacillus Calmette-Guérin (BCG) therapy. This option is exercisable on marketing approval from the US FDA. This will create a new US oncology division with the specialist knowledge and presence to introduce novel advanced therapies to the market.
Major Market Drivers and Restraints:
• Innovative drugs driving the market
• Increase in research & development in oncology therapeutic area
• Developments in genomics & proteomics
• Adverse events of treatment
• Cost associated with the treatment
• Low success rate in clinical testing for oncology drugs
Some of the major countries covered in this report are
• South Korea,
• Saudi Arabia,
• South Africa
• Brazil among others.
Click Here for Table of Content to Better Understanding of Report @ databridgemarketresearch.com/toc/?dbmr=global-prostate-ca...
On the basis of drug type, the market is classified into
• hormonal therapy,
• luteinizing hormone-releasing hormone (LHRH) agonist,
• targeted therapy,
On the basis of distribution channel
• hospital pharmacies,
• retail pharmacies,
• online pharmacies
Based on geography
• North America & South America,
• Middle East & Africa
Key questions answered in this report
1. What will be the market size in 2025 and what will the growth rate?
2. What are the key market trends?
3. What is driving this market?
4. What are the challenges to market growth?
5. Who are the key vendors in this market space?
Questions? We’ll Put You On The Right Path Request Analyst Call @ databridgemarketresearch.com/speak-to-analyst/?dbmr=globa...
Global Revenue Cycle Management (RCM) Market – Industry Trends and Forecast to 2024
Global Revenue Cycle Management (RCM) Market By Product Type (Integrated RCM, Standalone RCM), By Stage (Front Office, Mid Office, Back Office), By End User (Hospitals, General Physicians, Labs, Others), By Deployment (Web-based, On-premise, Cloud-based), By Component (Software, Services), By Geography (North America, Europe, Asia Pacific, South America, Middle East & Africa) –Industry Trends and Forecast to 2024
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge Market Research
This release was published on openPR.
News-ID: 1307675 • Views: 459More releases